pharmaceuticals

Ever since blockchain burst onto the scene a decade ago as a technology primarily designed for use in the financial services industry, people have continually found new—and sometimes odd—applications for the technology. Blockchain has been applied to everything from “buying” time (sic!) to renting a supercomputer, yet when it comes to the life sciences, a […]

The Future Of Blockchain: The Use Cases Set To Reshape ...

 in blog  tagged API / blockchain / clinical / consent / life science / pharmaceuticals / sharing by
Ahead of Bio-IT World Expo 2019 (#BioIT19), Richard Shute from Curlew Research is interviewed by Bio-IT World on the ever-growing potential for blockchain and distributed ledger technology (DLT) in life sciences. Blockchain has great potential within the clinical arena to support enhanced data management at nearly every level, he maintains. Added to this its potential […]

Blockchain – Not Just For Bitcoin

 in Uncategorized  tagged blockchain / clinical / DLT / healthcare / life science / pharmaceuticals by
In a new article published on LinkedIn, Richard Shute, Curlew Research Consultant, explains why he believes blockchain and distributed ledger technology (DLT) can play a significant role in the good practice areas of the GxP domain to enhance compliance, quality and safety through improved trust and confidence. He explores how this can be accomplished by […]

Blockchain, Distributed Ledger Technology and GxP: The Trust Protocol Enhancing ...

 in blog  tagged blockchain / compliance / GxP / pharmaceuticals / regulatory by